{"id":20,"date":"2026-04-03T17:41:30","date_gmt":"2026-04-04T00:41:30","guid":{"rendered":"https:\/\/www.kalonahealth.com\/?page_id=20"},"modified":"2026-04-03T20:36:18","modified_gmt":"2026-04-04T03:36:18","slug":"hiv","status":"publish","type":"page","link":"https:\/\/www.kalonahealth.com\/hiv\/","title":{"rendered":"HIV"},"content":{"rendered":"\n<!--\n==========================================================\nKOLANAHEALTH.COM \u2014 \/hiv\/\nSINGLE CUSTOM HTML BLOCK \u2014 schema + CSS + HTML\n\nMASTER TEMPLATE v1.0 \u2014 2026-04-04\nPAGE TYPE: Condition Hub\nPAGE URL:  https:\/\/kolanahealth.com\/hiv\/\n301 REDIRECT: sunnypharma.info\/hiv-medications\/ \u2192 here\n\nURL ARCHITECTURE \u2014 LOCKED:\n  Every HIV article sits at \/hiv\/[slug]\/ \u2014 flat, two levels.\n  No sub-hubs regardless of topic. The hub page at \/hiv\/\n  handles all internal organization via linked sections.\n  Pattern applies identically to \/hcv\/ \/cancer\/ \/diabetes\/\n\nSEO TITLE:\n  HIV Education, Medications & Patient Resources 2026\n  | Kolana Health\n\nMETA DESCRIPTION:\n  Clinically reviewed HIV education \u2014 medications, costs,\n  financial assistance, PrEP, PEP, and living well with HIV\n  in 2026. No ads. No sponsored content. Just clear answers.\n==========================================================\n-->\n\n\n<!-- SCHEMA 1 OF 3 \u2014 MedicalWebPage -->\n<script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"MedicalWebPage\",\n  \"url\": \"https:\/\/kolanahealth.com\/hiv\/\",\n  \"name\": \"HIV Education, Medications & Patient Resources 2026\",\n  \"description\": \"Kolana Health's HIV education hub. Clinically reviewed guides covering antiretroviral medications, treatment costs, financial assistance, prevention, and living well with HIV in 2026.\",\n  \"datePublished\": \"2026-04-04\",\n  \"dateModified\": \"2026-04-04\",\n  \"lastReviewed\": \"2026-04-04\",\n  \"inLanguage\": \"en-US\",\n  \"medicalAudience\": { \"@type\": \"MedicalAudience\", \"audienceType\": \"Patient\" },\n  \"about\": {\n    \"@type\": \"MedicalCondition\",\n    \"name\": \"HIV\",\n    \"alternateName\": [\"Human Immunodeficiency Virus\", \"HIV-1\", \"HIV infection\"],\n    \"code\": { \"@type\": \"MedicalCode\", \"code\": \"B20\", \"codingSystem\": \"ICD-10\" },\n    \"associatedAnatomy\": { \"@type\": \"AnatomicalSystem\", \"name\": \"Immune system\" },\n    \"possibleTreatment\": { \"@type\": \"MedicalTherapy\", \"name\": \"Antiretroviral therapy (ART)\" }\n  },\n  \"author\": {\n    \"@type\": \"Person\",\n    \"name\": \"Ray Ashton\",\n    \"url\": \"https:\/\/kolanahealth.com\/ray-ashton\/\"\n  },\n  \"reviewedBy\": {\n    \"@type\": \"Person\",\n    \"name\": \"Dr. Neha Mishra MD\",\n    \"url\": \"https:\/\/kolanahealth.com\/dr-neha-mishra\/\"\n  },\n  \"isPartOf\": { \"@type\": \"WebSite\", \"name\": \"Kolana Health\", \"url\": \"https:\/\/kolanahealth.com\" },\n  \"publisher\": {\n    \"@type\": \"Organization\",\n    \"name\": \"Kolana Health\",\n    \"url\": \"https:\/\/kolanahealth.com\",\n    \"logo\": {\n      \"@type\": \"ImageObject\",\n      \"url\": \"https:\/\/kolanahealth.com\/wp-content\/uploads\/kolana-health-logo.png\",\n      \"width\": 250, \"height\": 60\n    }\n  }\n}\n<\/script>\n\n\n<!-- SCHEMA 2 OF 3 \u2014 BreadcrumbList -->\n<script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"BreadcrumbList\",\n  \"itemListElement\": [\n    { \"@type\": \"ListItem\", \"position\": 1, \"name\": \"Home\", \"item\": \"https:\/\/kolanahealth.com\/\" },\n    { \"@type\": \"ListItem\", \"position\": 2, \"name\": \"HIV\", \"item\": \"https:\/\/kolanahealth.com\/hiv\/\" }\n  ]\n}\n<\/script>\n\n\n<!-- SCHEMA 3 OF 3 \u2014 FAQPage -->\n<script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"FAQPage\",\n  \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is the most prescribed HIV medication in 2026?\",\n      \"acceptedAnswer\": { \"@type\": \"Answer\", \"text\": \"Biktarvy (bictegravir\/emtricitabine\/tenofovir alafenamide) is the most widely prescribed HIV-1 treatment in the United States as of 2026. It is a complete single-tablet regimen taken once daily. Other commonly prescribed options include Dovato, Cabenuva, and Descovy-based regimens.\" }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Can HIV be treated so the virus becomes undetectable?\",\n      \"acceptedAnswer\": { \"@type\": \"Answer\", \"text\": \"Yes. With consistent antiretroviral therapy (ART), most people living with HIV achieve an undetectable viral load within 3 to 6 months of starting treatment. U=U \u2014 Undetectable equals Untransmittable \u2014 means a person with an undetectable viral load cannot sexually transmit HIV to a partner. This is confirmed by the PARTNER and HPTN 052 studies and endorsed by the CDC, WHO, and NIH.\" }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How much do HIV medications cost in 2026?\",\n      \"acceptedAnswer\": { \"@type\": \"Answer\", \"text\": \"HIV medications carry high list prices \u2014 Biktarvy's wholesale cost is $4,216 per month in 2026 \u2014 but most patients pay far less. With commercial insurance and a manufacturer copay card, many patients pay $0 to $5 per month. Uninsured patients may qualify for free medication through Gilead's Patient Assistance Program, ADAP, or Ryan White clinics.\" }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is antiretroviral therapy (ART)?\",\n      \"acceptedAnswer\": { \"@type\": \"Answer\", \"text\": \"Antiretroviral therapy (ART) is the combination of medications used to treat HIV. ART does not cure HIV, but suppresses viral replication to undetectable levels, preserves immune function, prevents progression to AIDS, and prevents transmission to others. Current DHHS guidelines recommend starting ART as soon as possible after diagnosis, regardless of CD4 count.\" }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is U=U?\",\n      \"acceptedAnswer\": { \"@type\": \"Answer\", \"text\": \"U=U stands for Undetectable equals Untransmittable. A person living with HIV who maintains an undetectable viral load through consistent ART cannot sexually transmit HIV to their partners. This is supported by the PARTNER and HPTN 052 studies and endorsed by the CDC, WHO, NIH, and major HIV medical associations worldwide.\" }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What financial assistance is available for HIV medications?\",\n      \"acceptedAnswer\": { \"@type\": \"Answer\", \"text\": \"Multiple programs cover every situation: Gilead's Advancing Access copay card (commercially insured), Gilead's Patient Assistance Program (uninsured), the AIDS Drug Assistance Program \u2014 ADAP \u2014 run by each state, Ryan White HIV\/AIDS Program clinics, and nonprofit foundations including the Patient Advocate Foundation and PAN Foundation. Most uninsured patients can access HIV medications at no cost through at least one program.\" }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is the difference between HIV and AIDS?\",\n      \"acceptedAnswer\": { \"@type\": \"Answer\", \"text\": \"HIV (Human Immunodeficiency Virus) is the virus that attacks the immune system. AIDS (Acquired Immunodeficiency Syndrome) is the most advanced stage of HIV infection, defined by a CD4 count below 200 cells per cubic millimeter or the presence of certain opportunistic infections. With modern ART started promptly after diagnosis, the vast majority of people living with HIV never develop AIDS.\" }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is PrEP and who should take it?\",\n      \"acceptedAnswer\": { \"@type\": \"Answer\", \"text\": \"PrEP (pre-exposure prophylaxis) is medication taken by HIV-negative individuals to prevent HIV infection. When taken consistently, PrEP reduces the risk of HIV from sex by about 99% and from injection drug use by at least 74%. Current FDA-approved options include Truvada (oral, generic available), Descovy (oral), and Apretude (injectable, every 2 months). PrEP is recommended for anyone at substantial risk of HIV exposure.\" }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is there a cure for HIV?\",\n      \"acceptedAnswer\": { \"@type\": \"Answer\", \"text\": \"There is currently no widely available cure for HIV. A small number of patients have achieved functional cures through stem cell transplants under very specific conditions. Research into long-acting treatments, broadly neutralizing antibodies, and gene-editing approaches is ongoing. For the vast majority of people living with HIV, daily ART enables a near-normal life expectancy.\" }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What resources exist for people newly diagnosed with HIV?\",\n      \"acceptedAnswer\": { \"@type\": \"Answer\", \"text\": \"Start with these: find a local Ryan White clinic at findhivcare.hrsa.gov, find your state ADAP at nastad.org\/adap-watch, and call Gilead Advancing Access at 1-800-226-2056. Starting treatment quickly after diagnosis is strongly recommended \u2014 modern ART is highly effective, well-tolerated, and typically available at little or no cost.\" }\n    }\n  ]\n}\n<\/script>\n\n\n<!-- FONTS -->\n<link rel=\"preconnect\" href=\"https:\/\/fonts.googleapis.com\">\n<link rel=\"preconnect\" href=\"https:\/\/fonts.gstatic.com\" crossorigin>\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=Source+Sans+3:ital,wght@0,400;0,600;0,700;1,400&#038;family=Source+Serif+4:ital,wght@0,400;0,600;0,700;1,400&#038;display=swap\" rel=\"stylesheet\">\n\n\n<!-- CSS \u2014 COMPONENT STYLES ONLY -->\n<style>\n.kh *, .kh *::before, .kh *::after { box-sizing: border-box; margin: 0; padding: 0; }\n\n:root {\n  --kh-ink:          #1b2332;\n  --kh-body:         #3d4a5c;\n  --kh-muted:        #535f6e;\n  --kh-border:       #dce3eb;\n  --kh-bg:           #f6f8fb;\n  --kh-accent:       #1a6b5a;\n  --kh-accent-light: #e8f5f1;\n  --kh-accent-link:  #b2d8cf;\n  --kh-warn:         #b45309;\n  --kh-warn-bg:      #fffbeb;\n  --kh-danger:       #b91c1c;\n  --kh-danger-bg:    #fef2f2;\n  --kh-serif:        \"Source Serif 4\", Georgia, \"Times New Roman\", serif;\n  --kh-sans:         \"Source Sans 3\", -apple-system, BlinkMacSystemFont, \"Segoe UI\", sans-serif;\n}\n\n.kh { max-width: 720px; margin: 0 auto; font-family: var(--kh-serif); color: var(--kh-body); line-height: 1.78; font-size: 18px; padding: 0 20px; }\n.kh a { color: var(--kh-accent); text-decoration: underline; text-decoration-color: var(--kh-accent-link); text-underline-offset: 3px; }\n.kh a:hover { text-decoration-color: var(--kh-accent); }\n.kh h2 { font-family: var(--kh-sans); font-size: 22px; line-height: 1.3; font-weight: 700; color: var(--kh-ink); margin: 48px 0 16px; padding-bottom: 10px; border-bottom: 2px solid var(--kh-border); }\n.kh h3 { font-family: var(--kh-sans); font-size: 18px; font-weight: 700; color: var(--kh-ink); margin: 28px 0 8px; }\n.kh p { margin: 0 0 18px; }\n.kh ul, .kh ol { padding-left: 24px; margin: 8px 0 18px; }\n.kh li { margin-bottom: 6px; }\n.kh strong { color: var(--kh-ink); }\n.kh blockquote { margin: 24px 0; padding: 16px 24px; background: var(--kh-bg); border-left: 4px solid var(--kh-muted); font-style: italic; color: var(--kh-body); border-radius: 0 6px 6px 0; }\n\n\/* AVATAR *\/\n.kh-avatar { border-radius: 50%; overflow: hidden; flex-shrink: 0; background-size: cover; background-position: center top; box-shadow: 0 0 0 1px var(--kh-border); display: block; }\n.kh-avatar-44 { width: 44px; height: 44px; }\n.kh-avatar-36 { width: 36px; height: 36px; }\n\n\/* BYLINE *\/\n.kh-byline { display: flex; align-items: center; gap: 16px; margin: 0 0 20px; font-family: var(--kh-sans); font-size: 14px; color: var(--kh-muted); line-height: 1.6; flex-wrap: wrap; }\n.kh-byline-pair { display: flex; align-items: center; gap: 8px; flex-shrink: 0; }\n.kh-byline a { color: var(--kh-ink); font-weight: 700; text-decoration: none; }\n.kh-byline a:hover { text-decoration: underline; }\n.kh-byline-sep { color: var(--kh-border); margin: 0 4px; }\n\n\/* DISCLOSURE *\/\n.kh-disclosure { font-family: var(--kh-sans); font-size: 14px; line-height: 1.6; color: var(--kh-muted); background: var(--kh-bg); border: 1px solid var(--kh-border); border-radius: 6px; padding: 14px 18px; margin: 0 0 32px; }\n.kh-ep-link { display: flex; align-items: center; font-size: 14px; line-height: 1; margin-top: 8px; }\n\n\/* STAT STRIP *\/\n.kh-stats { display: grid; grid-template-columns: repeat(3, 1fr); gap: 12px; margin: 28px 0; font-family: var(--kh-sans); }\n.kh-stat { background: var(--kh-bg); border: 1px solid var(--kh-border); border-radius: 8px; padding: 16px; text-align: center; }\n.kh-stat-value { font-size: 26px; font-weight: 700; color: var(--kh-accent); line-height: 1.1; }\n.kh-stat-label { font-size: 13px; color: var(--kh-muted); margin-top: 4px; line-height: 1.4; }\n\n\/* CALLOUT *\/\n.kh-callout { font-family: var(--kh-sans); border-radius: 6px; padding: 16px 20px; margin: 24px 0; font-size: 15px; line-height: 1.6; }\n.kh-callout p { font-size: 15px; margin-bottom: 10px; }\n.kh-callout p:last-child { margin-bottom: 0; }\n.kh-callout-info  { background: var(--kh-accent-light); border-left: 4px solid var(--kh-accent); }\n.kh-callout-warn  { background: var(--kh-warn-bg);      border-left: 4px solid var(--kh-warn); }\n.kh-callout-danger{ background: var(--kh-danger-bg);    border-left: 4px solid var(--kh-danger); }\n\n\/* SECTION NAV *\/\n.kh-section-nav { background: var(--kh-bg); border: 1px solid var(--kh-border); border-radius: 8px; padding: 18px 22px; margin: 0 0 36px; font-family: var(--kh-sans); }\n.kh-section-nav-title { font-size: 13px; font-weight: 700; text-transform: uppercase; letter-spacing: 0.8px; color: var(--kh-muted); margin-bottom: 10px; }\n.kh-section-nav ol { padding-left: 18px; margin: 0; }\n.kh-section-nav li { margin-bottom: 4px; font-size: 15px; }\n.kh-section-nav a { color: var(--kh-accent); text-decoration: none; }\n.kh-section-nav a:hover { text-decoration: underline; }\n\n\/* KEY FACTS *\/\n.kh-keyfacts { background: var(--kh-bg); border: 1px solid var(--kh-border); border-radius: 8px; padding: 20px 24px; margin: 24px 0; font-family: var(--kh-sans); font-size: 15px; line-height: 1.6; }\n.kh-keyfacts-title { font-weight: 700; font-size: 14px; text-transform: uppercase; letter-spacing: 0.8px; color: var(--kh-accent); margin-bottom: 10px; }\n.kh-keyfacts ul { padding-left: 18px; margin: 0; }\n.kh-keyfacts li { margin-bottom: 6px; color: var(--kh-body); }\n\n\/* MEDICATION CARD GRID *\/\n.kh-med-grid { display: grid; grid-template-columns: 1fr 1fr; gap: 14px; margin: 24px 0; }\n.kh-med-card { background: #fff; border: 1px solid var(--kh-border); border-radius: 10px; padding: 18px 20px; font-family: var(--kh-sans); }\n.kh-med-card-name { font-size: 17px; font-weight: 700; color: var(--kh-ink); margin-bottom: 2px; }\n.kh-med-card-generic { font-size: 12px; color: var(--kh-muted); margin-bottom: 10px; font-style: italic; }\n.kh-med-card-detail { font-size: 13px; color: var(--kh-body); line-height: 1.5; margin-bottom: 5px; }\n.kh-med-card-detail strong { color: var(--kh-ink); font-weight: 600; }\n.kh-med-card-links { margin-top: 12px; padding-top: 10px; border-top: 1px solid #eef1f5; display: flex; flex-direction: column; gap: 4px; }\n.kh-med-card-links a { font-size: 13px; color: var(--kh-accent); text-decoration: none; }\n.kh-med-card-links a:hover { text-decoration: underline; }\n.kh-med-card-links a::before { content: '\\2192 '; }\n\n\/* TOPIC LINK GRID *\/\n.kh-topic-list { list-style: none; padding-left: 0; margin: 16px 0 24px; display: grid; grid-template-columns: 1fr 1fr; gap: 8px; font-family: var(--kh-sans); }\n.kh-topic-list li { margin: 0; }\n.kh-topic-list a { display: block; font-size: 15px; color: var(--kh-accent); text-decoration: none; padding: 8px 12px; background: var(--kh-bg); border: 1px solid var(--kh-border); border-radius: 6px; line-height: 1.4; }\n.kh-topic-list a:hover { border-color: var(--kh-accent); background: var(--kh-accent-light); }\n.kh-topic-list a::before { content: '\\2192 '; font-size: 13px; }\n\n\/* FAQ *\/\n.kh-faq { margin: 24px 0; }\n.kh-faq-item { padding: 16px 0; border-bottom: 1px solid var(--kh-border); }\n.kh-faq-item:last-child { border-bottom: none; }\n.kh-faq-q { font-family: var(--kh-sans); font-weight: 700; font-size: 17px; color: var(--kh-ink); margin-bottom: 8px; }\n.kh-faq-a { margin: 0; font-size: 16px; }\n\n\/* HOW WE REVIEWED *\/\n.kh-reviewed { border-top: 2px solid var(--kh-border); padding: 16px 0; margin-top: 36px; font-family: var(--kh-sans); }\n.kh-reviewed-byline { display: flex; align-items: center; gap: 12px; margin-bottom: 14px; font-size: 14px; color: var(--kh-muted); flex-wrap: wrap; }\n.kh-reviewed-byline .kh-byline-pair { gap: 8px; }\n.kh-reviewed-byline a { color: var(--kh-ink); font-weight: 700; text-decoration: none; }\n.kh-reviewed-byline a:hover { text-decoration: underline; }\n.kh-reviewed-body { font-size: 14px; line-height: 1.6; color: var(--kh-muted); padding-top: 12px; border-top: 1px solid #eef1f5; }\n.kh-reviewed-body p { font-size: 14px; margin: 0 0 6px; }\n\n\/* REFERENCES *\/\n.kh-refs { font-family: var(--kh-sans); font-size: 13px; line-height: 1.6; color: var(--kh-muted); margin-top: 32px; padding-top: 20px; border-top: 1px solid var(--kh-border); }\n.kh-refs h2 { font-size: 16px; border-bottom: none; margin: 0 0 10px; color: var(--kh-muted); }\n.kh-refs ol { padding-left: 18px; }\n.kh-refs li { margin-bottom: 5px; }\n\n\/* MOBILE \u2014 600px *\/\n@media (max-width: 600px) {\n  .kh { font-size: 17px; padding: 0 16px; }\n  .kh h2 { font-size: 20px; margin-top: 36px; }\n  .kh h3 { font-size: 17px; }\n  .kh-byline { gap: 8px; flex-direction: column; align-items: flex-start; }\n  .kh-byline-sep { display: none; }\n  .kh-avatar-44 { width: 36px; height: 36px; }\n  .kh-stats { grid-template-columns: 1fr 1fr; }\n  .kh-stat-value { font-size: 22px; }\n  .kh-med-grid { grid-template-columns: 1fr; }\n  .kh-topic-list { grid-template-columns: 1fr; }\n  .kh-callout { padding: 14px 16px; }\n  .kh-keyfacts { padding: 16px 18px; }\n  .kh-faq-q { font-size: 16px; }\n}\n\n\/* SMALL \u2014 375px *\/\n@media (max-width: 375px) {\n  .kh { padding: 0 12px; }\n  .kh h2 { font-size: 18px; }\n  .kh-stats { grid-template-columns: 1fr; }\n}\n<\/style>\n\n\n<!-- PAGE CONTENT -->\n<div class=\"kh\">\n\n<!-- BYLINE -->\n<div class=\"kh-byline\">\n  <div class=\"kh-byline-pair\">\n    <div class=\"kh-avatar kh-avatar-44\" style=\"background-image:url('https:\/\/kolanahealth.com\/wp-content\/uploads\/2026\/03\/Dr-Neha-Mishra.jpg');\" role=\"img\" aria-label=\"Dr. Neha Mishra, MD\"><\/div>\n    <span>Medically reviewed by <a href=\"https:\/\/kolanahealth.com\/dr-neha-mishra\/\" target=\"_blank\" rel=\"noopener\">Dr. Neha Mishra, MD<\/a><\/span>\n  <\/div>\n  <span class=\"kh-byline-sep\">&mdash;<\/span>\n  <div class=\"kh-byline-pair\">\n    <div class=\"kh-avatar kh-avatar-44\" style=\"background-image:url('https:\/\/kolanahealth.com\/wp-content\/uploads\/2026\/03\/Ray-Ashton.jpg');\" role=\"img\" aria-label=\"Ray Ashton\"><\/div>\n    <span>Written by <a href=\"https:\/\/kolanahealth.com\/ray-ashton\/\" target=\"_blank\" rel=\"noopener\">Ray Ashton<\/a><\/span>\n  <\/div>\n  <span class=\"kh-byline-sep\">&mdash;<\/span>\n  <span>Updated April 4, 2026<\/span>\n<\/div>\n\n<!-- DISCLOSURE -->\n<div class=\"kh-disclosure\">\n  <strong>Editorial disclosure:<\/strong> Kolana Health provides this page for educational purposes only. We are not a medical provider and do not dispense prescriptions or direct readers to any pharmacy or commercial service. All decisions about HIV treatment should be made in consultation with your healthcare provider.\n  <span class=\"kh-ep-link\"><a href=\"https:\/\/kolanahealth.com\/editorial-policy\/\" target=\"_blank\" rel=\"noopener\">Read our editorial standards &rarr;<\/a><\/span>\n<\/div>\n\n<!-- SECTION NAV -->\n<div class=\"kh-section-nav\">\n  <div class=\"kh-section-nav-title\">On this page<\/div>\n  <ol>\n    <li><a href=\"#what-is-hiv\">What is HIV<\/a><\/li>\n    <li><a href=\"#treatment\">Antiretroviral therapy (ART)<\/a><\/li>\n    <li><a href=\"#medications\">HIV medications &mdash; full guide index<\/a><\/li>\n    <li><a href=\"#cost\">What HIV medications cost<\/a><\/li>\n    <li><a href=\"#assistance\">Financial assistance programs<\/a><\/li>\n    <li><a href=\"#prevention\">Prevention &mdash; PrEP and PEP<\/a><\/li>\n    <li><a href=\"#living\">Living with HIV<\/a><\/li>\n    <li><a href=\"#faq\">Frequently asked questions<\/a><\/li>\n  <\/ol>\n<\/div>\n\n\n<p>HIV (Human Immunodeficiency Virus) is a chronic but fully manageable condition. With modern antiretroviral therapy, people living with HIV achieve an undetectable viral load, protect their long-term immune health, and live a near-normal life expectancy. The pages collected here cover every aspect of HIV care that matters to patients &mdash; from understanding your treatment options to navigating the cost of your medication.<\/p>\n\n<p>Every guide on Kolana Health is written in plain language, medically reviewed before publication, and updated when evidence changes. There are no ads, no sponsored content, and no financial relationship with any pharmaceutical company or pharmacy.<\/p>\n\n\n<!-- STAT STRIP -->\n<div class=\"kh-stats\">\n  <div class=\"kh-stat\">\n    <div class=\"kh-stat-value\">1.2M<\/div>\n    <div class=\"kh-stat-label\">People living with HIV in the United States<\/div>\n  <\/div>\n  <div class=\"kh-stat\">\n    <div class=\"kh-stat-value\">U=U<\/div>\n    <div class=\"kh-stat-label\">Undetectable = Untransmittable &mdash; the most important fact in HIV care today<\/div>\n  <\/div>\n  <div class=\"kh-stat\">\n    <div class=\"kh-stat-value\">$0<\/div>\n    <div class=\"kh-stat-label\">What most insured patients pay per month with assistance programs<\/div>\n  <\/div>\n<\/div>\n\n\n<h2 id=\"what-is-hiv\">What Is HIV<\/h2>\n\n<p>HIV is a virus that attacks CD4 cells (T cells) &mdash; the immune system&rsquo;s primary defense against infection. Without treatment, HIV progressively damages the immune system until it can no longer defend the body against infections and cancers that a healthy immune system would control. That advanced stage is called AIDS.<\/p>\n\n<p>With treatment, this progression is prevented entirely for the vast majority of people. HIV is transmitted through specific bodily fluids: blood, semen, vaginal fluids, rectal fluids, and breast milk. It is not transmitted through casual contact, saliva, air, water, food, or insects.<\/p>\n\n<blockquote>HIV is not a death sentence. With consistent antiretroviral treatment, people living with HIV today have a near-normal life expectancy and cannot transmit the virus to others when their viral load is undetectable.<\/blockquote>\n\n<div class=\"kh-keyfacts\">\n  <div class=\"kh-keyfacts-title\">HIV &mdash; Key Facts for Patients<\/div>\n  <ul>\n    <li><strong>Cause:<\/strong> Human Immunodeficiency Virus (HIV-1 is the predominant global strain)<\/li>\n    <li><strong>Transmission:<\/strong> Blood, sexual fluids, breast milk &mdash; not casual contact<\/li>\n    <li><strong>Diagnosis:<\/strong> HIV antibody\/antigen test; confirmed by viral load and CD4 count<\/li>\n    <li><strong>Treatment:<\/strong> Antiretroviral therapy (ART) &mdash; highly effective, typically once-daily<\/li>\n    <li><strong>Goal of treatment:<\/strong> Undetectable viral load (&lt;50 copies per mL of blood)<\/li>\n    <li><strong>U=U:<\/strong> Undetectable = Untransmittable &mdash; confirmed by PARTNER and HPTN 052 studies<\/li>\n    <li><strong>Life expectancy:<\/strong> Near-normal with consistent, sustained treatment<\/li>\n    <li><strong>Cure:<\/strong> Not yet widely available; active research is ongoing<\/li>\n  <\/ul>\n<\/div>\n\n\n<h2 id=\"treatment\">Antiretroviral Therapy (ART)<\/h2>\n\n<p>Antiretroviral therapy is the combination of medications that suppresses HIV replication in the body. ART does not eliminate HIV, but reduces the viral load to undetectable levels &mdash; protecting the immune system, preventing progression to AIDS, and preventing transmission to others through sex.<\/p>\n\n<p>Current DHHS guidelines recommend starting ART as soon as possible after diagnosis, regardless of CD4 count or viral load. Most modern regimens are a single tablet taken once daily. Adherence is critical: missed doses allow the virus to replicate and can lead to drug resistance that limits future treatment options.<\/p>\n\n<div class=\"kh-callout kh-callout-info\">\n  <p><strong>U=U &mdash; Undetectable equals Untransmittable:<\/strong> A person living with HIV who maintains an undetectable viral load on ART cannot sexually transmit HIV to a partner. This is confirmed by the landmark PARTNER study (2016, 2019) and HPTN 052, and endorsed by the CDC, WHO, NIH, and every major HIV medical association. Source: <a href=\"https:\/\/www.cdc.gov\/hiv\/risk\/estimates\/index.html\" target=\"_blank\" rel=\"noopener noreferrer\">CDC<\/a>.<\/p>\n<\/div>\n\n<p>The main classes of antiretroviral drugs used today are integrase strand transfer inhibitors (INSTIs), nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), and capsid inhibitors. Most patients today are prescribed an INSTI-based regimen for its high efficacy, high barrier to resistance, and favorable side effect profile.<\/p>\n\n\n<h2 id=\"medications\">HIV Medications &mdash; Full Guide Index<\/h2>\n\n<p>The guides below cover every major HIV medication in depth: how it works, what it costs, what the side effects are, how to access financial assistance, and how it compares to alternatives. This index grows as new guides are published.<\/p>\n\n<h3>Complete Regimens &mdash; Single Tablet, Once Daily<\/h3>\n\n<div class=\"kh-med-grid\">\n\n  <div class=\"kh-med-card\">\n    <div class=\"kh-med-card-name\">Biktarvy<\/div>\n    <div class=\"kh-med-card-generic\">bictegravir \/ emtricitabine \/ tenofovir alafenamide<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Class:<\/strong> INSTI + 2 NRTIs<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Dosing:<\/strong> Once daily, with or without food<\/div>\n    <div class=\"kh-med-card-detail\"><strong>List price:<\/strong> $4,216\/mo (Jan 2026)<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Most patients pay:<\/strong> $0&ndash;$5\/mo with assistance<\/div>\n    <div class=\"kh-med-card-links\">\n      <a href=\"https:\/\/kolanahealth.com\/hiv\/biktarvy-cost\/\" target=\"_blank\" rel=\"noopener\">Biktarvy cost &mdash; what you pay in 2026<\/a>\n      <a href=\"https:\/\/kolanahealth.com\/hiv\/biktarvy-cost-without-insurance\/\" target=\"_blank\" rel=\"noopener\">Biktarvy without insurance<\/a>\n      <a href=\"https:\/\/kolanahealth.com\/hiv\/biktarvy-generic\/\" target=\"_blank\" rel=\"noopener\">Biktarvy generic &mdash; what exists in 2026<\/a>\n      <a href=\"https:\/\/kolanahealth.com\/hiv\/biktarvy-side-effects\/\" target=\"_blank\" rel=\"noopener\">Biktarvy side effects<\/a>\n    <\/div>\n  <\/div>\n\n  <div class=\"kh-med-card\">\n    <div class=\"kh-med-card-name\">Dovato<\/div>\n    <div class=\"kh-med-card-generic\">dolutegravir \/ lamivudine<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Class:<\/strong> INSTI + NRTI (2-drug regimen)<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Dosing:<\/strong> Once daily, with or without food<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Note:<\/strong> Not for patients with HBV co-infection<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Most patients pay:<\/strong> $0&ndash;$5\/mo with assistance<\/div>\n    <div class=\"kh-med-card-links\">\n      <a href=\"https:\/\/kolanahealth.com\/hiv\/dovato-cost\/\" target=\"_blank\" rel=\"noopener\">Dovato cost &mdash; what you pay in 2026<\/a>\n      <a href=\"https:\/\/kolanahealth.com\/hiv\/dovato-side-effects\/\" target=\"_blank\" rel=\"noopener\">Dovato side effects<\/a>\n      <a href=\"https:\/\/kolanahealth.com\/hiv\/biktarvy-vs-dovato\/\" target=\"_blank\" rel=\"noopener\">Biktarvy vs Dovato<\/a>\n    <\/div>\n  <\/div>\n\n  <div class=\"kh-med-card\">\n    <div class=\"kh-med-card-name\">Cabenuva<\/div>\n    <div class=\"kh-med-card-generic\">cabotegravir \/ rilpivirine injectable<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Class:<\/strong> INSTI + NNRTI (long-acting injectable)<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Dosing:<\/strong> Once monthly or every 2 months injection<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Note:<\/strong> First complete long-acting injectable regimen<\/div>\n    <div class=\"kh-med-card-links\">\n      <a href=\"https:\/\/kolanahealth.com\/hiv\/cabenuva-cost\/\" target=\"_blank\" rel=\"noopener\">Cabenuva cost &mdash; what you pay<\/a>\n      <a href=\"https:\/\/kolanahealth.com\/hiv\/cabenuva-side-effects\/\" target=\"_blank\" rel=\"noopener\">Cabenuva side effects<\/a>\n    <\/div>\n  <\/div>\n\n  <div class=\"kh-med-card\">\n    <div class=\"kh-med-card-name\">Symtuza<\/div>\n    <div class=\"kh-med-card-generic\">darunavir \/ cobicistat \/ emtricitabine \/ TAF<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Class:<\/strong> PI + booster + 2 NRTIs<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Dosing:<\/strong> Once daily with food<\/div>\n    <div class=\"kh-med-card-links\">\n      <a href=\"https:\/\/kolanahealth.com\/hiv\/symtuza-cost\/\" target=\"_blank\" rel=\"noopener\">Symtuza cost &mdash; what you pay<\/a>\n      <a href=\"https:\/\/kolanahealth.com\/hiv\/symtuza-side-effects\/\" target=\"_blank\" rel=\"noopener\">Symtuza side effects<\/a>\n    <\/div>\n  <\/div>\n\n<\/div>\n\n<h3>PrEP Medications &mdash; HIV Prevention<\/h3>\n\n<div class=\"kh-med-grid\">\n\n  <div class=\"kh-med-card\">\n    <div class=\"kh-med-card-name\">Descovy for PrEP<\/div>\n    <div class=\"kh-med-card-generic\">emtricitabine \/ tenofovir alafenamide<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Use:<\/strong> PrEP for at-risk HIV-negative adults<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Dosing:<\/strong> Once daily oral tablet<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Efficacy:<\/strong> ~99% reduction in HIV risk from sex<\/div>\n    <div class=\"kh-med-card-links\">\n      <a href=\"https:\/\/kolanahealth.com\/hiv\/descovy-prep-cost\/\" target=\"_blank\" rel=\"noopener\">Descovy PrEP cost<\/a>\n      <a href=\"https:\/\/kolanahealth.com\/hiv\/prep\/\" target=\"_blank\" rel=\"noopener\">PrEP &mdash; complete patient guide<\/a>\n    <\/div>\n  <\/div>\n\n  <div class=\"kh-med-card\">\n    <div class=\"kh-med-card-name\">Apretude<\/div>\n    <div class=\"kh-med-card-generic\">cabotegravir injectable<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Use:<\/strong> Long-acting injectable PrEP<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Dosing:<\/strong> Injection every 2 months<\/div>\n    <div class=\"kh-med-card-detail\"><strong>Note:<\/strong> First FDA-approved injectable PrEP option<\/div>\n    <div class=\"kh-med-card-links\">\n      <a href=\"https:\/\/kolanahealth.com\/hiv\/apretude-cost\/\" target=\"_blank\" rel=\"noopener\">Apretude cost<\/a>\n      <a href=\"https:\/\/kolanahealth.com\/hiv\/prep\/\" target=\"_blank\" rel=\"noopener\">PrEP &mdash; complete patient guide<\/a>\n    <\/div>\n  <\/div>\n\n<\/div>\n\n<h3>All HIV Topics on Kolana Health<\/h3>\n\n<ul class=\"kh-topic-list\">\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/biktarvy-cost\/\" target=\"_blank\" rel=\"noopener\">Biktarvy cost 2026<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/biktarvy-cost-without-insurance\/\" target=\"_blank\" rel=\"noopener\">Biktarvy without insurance<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/biktarvy-generic\/\" target=\"_blank\" rel=\"noopener\">Biktarvy generic<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/biktarvy-side-effects\/\" target=\"_blank\" rel=\"noopener\">Biktarvy side effects<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/dovato-cost\/\" target=\"_blank\" rel=\"noopener\">Dovato cost 2026<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/dovato-side-effects\/\" target=\"_blank\" rel=\"noopener\">Dovato side effects<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/biktarvy-vs-dovato\/\" target=\"_blank\" rel=\"noopener\">Biktarvy vs Dovato<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/cabenuva-cost\/\" target=\"_blank\" rel=\"noopener\">Cabenuva cost 2026<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/symtuza-cost\/\" target=\"_blank\" rel=\"noopener\">Symtuza cost 2026<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/prep\/\" target=\"_blank\" rel=\"noopener\">PrEP &mdash; complete guide<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/pep\/\" target=\"_blank\" rel=\"noopener\">PEP &mdash; complete guide<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/descovy-prep-cost\/\" target=\"_blank\" rel=\"noopener\">Descovy PrEP cost<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/apretude-cost\/\" target=\"_blank\" rel=\"noopener\">Apretude cost<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/cd4-count\/\" target=\"_blank\" rel=\"noopener\">CD4 count explained<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/viral-load\/\" target=\"_blank\" rel=\"noopener\">Viral load explained<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/u-equals-u\/\" target=\"_blank\" rel=\"noopener\">U=U &mdash; what it means for you<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/treatment-guide\/\" target=\"_blank\" rel=\"noopener\">HIV treatment guide 2026<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/newly-diagnosed\/\" target=\"_blank\" rel=\"noopener\">Newly diagnosed &mdash; what to do first<\/a><\/li>\n<\/ul>\n\n\n<h2 id=\"cost\">What HIV Medications Cost in 2026<\/h2>\n\n<p>HIV medications carry some of the highest list prices in U.S. pharmacy. Biktarvy&rsquo;s wholesale cost is $4,216 per month as of January 2026. But list price is not what most patients pay. The United States has a layered system of manufacturer assistance programs, federal safety nets, and independent nonprofit foundations designed specifically to ensure that cost is never an absolute barrier to HIV treatment.<\/p>\n\n<div class=\"kh-keyfacts\">\n  <div class=\"kh-keyfacts-title\">What Most Patients Actually Pay Per Month<\/div>\n  <ul>\n    <li><strong>Commercial insurance + copay card:<\/strong> $0&ndash;$5<\/li>\n    <li><strong>Medicare Part D + Extra Help (LIS):<\/strong> $4&ndash;$9<\/li>\n    <li><strong>Medicaid:<\/strong> $0&ndash;$3 in most states<\/li>\n    <li><strong>Uninsured + Gilead PAP or state ADAP:<\/strong> $0<\/li>\n    <li><strong>Uninsured with no assistance programs:<\/strong> $3,800&ndash;$5,300+ (retail cash price)<\/li>\n  <\/ul>\n<\/div>\n\n<div class=\"kh-callout kh-callout-danger\">\n  <p><strong>If you are facing a cost barrier: do not stop your medication.<\/strong> Interrupting antiretroviral therapy causes viral rebound, immune decline, and resistance that can limit your future treatment options. Contact your prescriber, insurer, and Gilead Advancing Access (1-800-226-2056) before making any decision about stopping or skipping doses. Programs exist for every coverage situation.<\/p>\n<\/div>\n\n<p>See the full cost breakdown for each medication in the guides linked above. The most detailed guide covers the most prescribed HIV treatment: <a href=\"https:\/\/kolanahealth.com\/hiv\/biktarvy-cost\/\" target=\"_blank\" rel=\"noopener\">Biktarvy cost in 2026 &rarr;<\/a><\/p>\n\n\n<h2 id=\"assistance\">Financial Assistance Programs for HIV Medications<\/h2>\n\n<p>Every uninsured or underinsured person living with HIV in the United States qualifies for at least one of the following programs. Together they cover every coverage situation:<\/p>\n\n<ul>\n  <li><strong><a href=\"https:\/\/www.gileadadvancingaccess.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">Gilead Advancing Access<\/a><\/strong> &mdash; Copay card for commercially insured patients (up to $7,200\/year); free medication through the Patient Assistance Program (PAP) for uninsured patients. Call 1-800-226-2056 or enroll online.<\/li>\n  <li><strong>AIDS Drug Assistance Program (ADAP)<\/strong> &mdash; State-run programs providing HIV medications at no cost or minimal copay to eligible low-income individuals. Find your state&rsquo;s program at <a href=\"https:\/\/www.nastad.org\/adap-watch\" target=\"_blank\" rel=\"noopener noreferrer\">nastad.org\/adap-watch<\/a>.<\/li>\n  <li><strong><a href=\"https:\/\/ryanwhite.hrsa.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">Ryan White HIV\/AIDS Program<\/a><\/strong> &mdash; The largest federal safety-net program for people with HIV who are uninsured or underinsured. Funds clinics, medications through ADAP, and support services. Find a clinic at <a href=\"https:\/\/findhivcare.hrsa.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">findhivcare.hrsa.gov<\/a>.<\/li>\n  <li><strong><a href=\"https:\/\/www.patientadvocate.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">Patient Advocate Foundation<\/a><\/strong> &mdash; Copay relief and free case management for insurance denials and appeals.<\/li>\n  <li><strong><a href=\"https:\/\/www.panfoundation.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">PAN Foundation<\/a><\/strong> &mdash; Grants covering copays, deductibles, and insurance premiums for HIV treatment. Critical for Medicare patients who cannot use manufacturer copay cards.<\/li>\n  <li><strong><a href=\"https:\/\/www.healthwellfoundation.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">HealthWell Foundation<\/a><\/strong> &mdash; HIV\/AIDS fund when funding is available.<\/li>\n  <li><strong>340B Drug Pricing Program<\/strong> &mdash; If you receive care at a Ryan White clinic or federally qualified health center, your medications may be available at significantly reduced cost through 340B pricing. Ask your clinic directly if they participate.<\/li>\n<\/ul>\n\n<div class=\"kh-callout kh-callout-warn\">\n  <p><strong>Medicare patients:<\/strong> Gilead&rsquo;s copay card cannot be used with Medicare, Medicaid, or other government-funded insurance. The PAN Foundation, HealthWell Foundation, and Patient Advocate Foundation all operate programs specifically designed for Medicare patients with HIV. These nonprofits are your primary resource if you are on Medicare and facing high medication costs.<\/p>\n<\/div>\n\n\n<h2 id=\"prevention\">Prevention &mdash; PrEP and PEP<\/h2>\n\n<p>HIV is highly preventable with two medication-based strategies that provide near-complete protection for HIV-negative individuals at risk of exposure.<\/p>\n\n<p><strong>PrEP (Pre-Exposure Prophylaxis)<\/strong> is medication taken by HIV-negative individuals before potential exposure to HIV. When taken consistently, PrEP reduces the risk of HIV from sex by approximately 99% and from injection drug use by at least 74%. Current FDA-approved options include Truvada (oral, generic available), Descovy (oral), and Apretude (injectable, every 2 months). PrEP is covered by most insurance plans and available at no cost to uninsured individuals through the federal Ready, Set, PrEP program.<\/p>\n\n<p><strong>PEP (Post-Exposure Prophylaxis)<\/strong> is emergency medication taken after a potential HIV exposure. PEP must be started within 72 hours of exposure and taken for 28 consecutive days. It is not a substitute for PrEP but can prevent HIV infection when initiated quickly after a high-risk exposure event.<\/p>\n\n<ul class=\"kh-topic-list\">\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/prep\/\" target=\"_blank\" rel=\"noopener\">PrEP &mdash; complete patient guide<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/pep\/\" target=\"_blank\" rel=\"noopener\">PEP &mdash; complete patient guide<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/descovy-prep-cost\/\" target=\"_blank\" rel=\"noopener\">Descovy PrEP cost<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/apretude-cost\/\" target=\"_blank\" rel=\"noopener\">Apretude injectable PrEP cost<\/a><\/li>\n<\/ul>\n\n\n<h2 id=\"living\">Living With HIV<\/h2>\n\n<p>A diagnosis of HIV changes your life, but it does not end it. With consistent treatment, people living with HIV today maintain near-normal life expectancy, cannot transmit the virus to sexual partners, and live full and active lives. The guides below address the practical questions that come after diagnosis &mdash; monitoring, mental health, relationships, and day-to-day life with the condition.<\/p>\n\n<ul class=\"kh-topic-list\">\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/newly-diagnosed\/\" target=\"_blank\" rel=\"noopener\">Newly diagnosed &mdash; what to do first<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/cd4-count\/\" target=\"_blank\" rel=\"noopener\">CD4 count &mdash; what it means<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/viral-load\/\" target=\"_blank\" rel=\"noopener\">Viral load &mdash; what it means<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/u-equals-u\/\" target=\"_blank\" rel=\"noopener\">U=U &mdash; what it means for you<\/a><\/li>\n  <li><a href=\"https:\/\/kolanahealth.com\/hiv\/treatment-guide\/\" target=\"_blank\" rel=\"noopener\">HIV treatment guide 2026<\/a><\/li>\n<\/ul>\n\n\n<h2 id=\"faq\">Frequently Asked Questions<\/h2>\n\n<div class=\"kh-faq\">\n\n  <div class=\"kh-faq-item\">\n    <div class=\"kh-faq-q\">What is the most prescribed HIV medication in 2026?<\/div>\n    <p class=\"kh-faq-a\">Biktarvy (bictegravir\/emtricitabine\/tenofovir alafenamide) is the most widely prescribed HIV-1 treatment in the United States as of 2026. It is a complete single-tablet regimen taken once daily. Other commonly prescribed options include Dovato, Cabenuva (injectable, monthly or every two months), and Descovy-based regimens.<\/p>\n  <\/div>\n\n  <div class=\"kh-faq-item\">\n    <div class=\"kh-faq-q\">Can HIV be treated so the virus becomes undetectable?<\/div>\n    <p class=\"kh-faq-a\">Yes. With consistent antiretroviral therapy, most people living with HIV achieve an undetectable viral load within 3&ndash;6 months of starting treatment. U=U &mdash; Undetectable equals Untransmittable &mdash; means a person with an undetectable viral load cannot sexually transmit HIV to a partner. This is confirmed by the PARTNER and HPTN 052 studies and endorsed by the CDC, WHO, and NIH.<\/p>\n  <\/div>\n\n  <div class=\"kh-faq-item\">\n    <div class=\"kh-faq-q\">How much do HIV medications cost in 2026?<\/div>\n    <p class=\"kh-faq-a\">HIV medications carry high list prices &mdash; Biktarvy&rsquo;s wholesale cost is $4,216 per month in 2026 &mdash; but most insured patients pay $0 to $5 per month with manufacturer copay card assistance. Uninsured patients may qualify for free medication through Gilead&rsquo;s Patient Assistance Program or their state ADAP. See the full <a href=\"https:\/\/kolanahealth.com\/hiv\/biktarvy-cost\/\" target=\"_blank\" rel=\"noopener\">Biktarvy cost guide<\/a> for a detailed breakdown by coverage type.<\/p>\n  <\/div>\n\n  <div class=\"kh-faq-item\">\n    <div class=\"kh-faq-q\">What is the difference between HIV and AIDS?<\/div>\n    <p class=\"kh-faq-a\">HIV is the virus. AIDS is the most advanced stage of HIV infection, defined by a CD4 count below 200 cells per cubic millimeter or the presence of certain opportunistic infections. With modern ART started promptly after diagnosis, the vast majority of people living with HIV never develop AIDS.<\/p>\n  <\/div>\n\n  <div class=\"kh-faq-item\">\n    <div class=\"kh-faq-q\">What is PrEP and who should take it?<\/div>\n    <p class=\"kh-faq-a\">PrEP (pre-exposure prophylaxis) is medication taken by HIV-negative individuals to prevent infection. When taken as prescribed, PrEP reduces the risk of HIV from sex by approximately 99%. Current options include Truvada, Descovy, and Apretude (injectable, every 2 months). PrEP is recommended for anyone at substantial risk of HIV exposure. See the complete <a href=\"https:\/\/kolanahealth.com\/hiv\/prep\/\" target=\"_blank\" rel=\"noopener\">PrEP guide &rarr;<\/a><\/p>\n  <\/div>\n\n  <div class=\"kh-faq-item\">\n    <div class=\"kh-faq-q\">What financial assistance is available for HIV medications?<\/div>\n    <p class=\"kh-faq-a\">Programs cover every situation: Gilead&rsquo;s copay card (commercially insured, up to $7,200\/year), Gilead&rsquo;s Patient Assistance Program (uninsured), state ADAP programs, Ryan White clinics, and nonprofit foundations including the Patient Advocate Foundation, PAN Foundation, and HealthWell Foundation. Call Gilead Advancing Access at 1-800-226-2056 as a first step regardless of your insurance status.<\/p>\n  <\/div>\n\n  <div class=\"kh-faq-item\">\n    <div class=\"kh-faq-q\">Is there a cure for HIV?<\/div>\n    <p class=\"kh-faq-a\">There is currently no widely available cure for HIV. A small number of patients have achieved functional cures through stem cell transplants under very specific clinical conditions. Research into curative approaches &mdash; including broadly neutralizing antibodies and gene editing &mdash; is active and ongoing. For the vast majority of people living with HIV, daily ART enables near-normal life expectancy and full quality of life.<\/p>\n  <\/div>\n\n  <div class=\"kh-faq-item\">\n    <div class=\"kh-faq-q\">What should I do if I was just diagnosed with HIV?<\/div>\n    <p class=\"kh-faq-a\">Start treatment as soon as possible &mdash; current guidelines recommend beginning ART immediately after diagnosis. Find a local Ryan White clinic at <a href=\"https:\/\/findhivcare.hrsa.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">findhivcare.hrsa.gov<\/a>, locate your state ADAP at <a href=\"https:\/\/www.nastad.org\/adap-watch\" target=\"_blank\" rel=\"noopener noreferrer\">nastad.org\/adap-watch<\/a>, and call Gilead Advancing Access at 1-800-226-2056 to understand your medication assistance options. Modern HIV treatment is highly effective, well-tolerated, and typically available at low or no cost.<\/p>\n  <\/div>\n\n<\/div>\n\n\n<!-- HOW WE REVIEWED -->\n<div class=\"kh-reviewed\">\n  <div class=\"kh-reviewed-byline\">\n    <div class=\"kh-byline-pair\">\n      <div class=\"kh-avatar kh-avatar-36\" style=\"background-image:url('https:\/\/kolanahealth.com\/wp-content\/uploads\/2026\/03\/Dr-Neha-Mishra.jpg');\" role=\"img\" aria-label=\"Dr. Neha Mishra, MD\"><\/div>\n      <span>Medically reviewed by <a href=\"https:\/\/kolanahealth.com\/dr-neha-mishra\/\" target=\"_blank\" rel=\"noopener\">Dr. Neha Mishra, MD<\/a><\/span>\n    <\/div>\n    <span class=\"kh-byline-sep\">&mdash;<\/span>\n    <div class=\"kh-byline-pair\">\n      <div class=\"kh-avatar kh-avatar-36\" style=\"background-image:url('https:\/\/kolanahealth.com\/wp-content\/uploads\/2026\/03\/Ray-Ashton.jpg');\" role=\"img\" aria-label=\"Ray Ashton\"><\/div>\n      <span>Written by <a href=\"https:\/\/kolanahealth.com\/ray-ashton\/\" target=\"_blank\" rel=\"noopener\">Ray Ashton<\/a><\/span>\n    <\/div>\n    <span class=\"kh-byline-sep\">&mdash;<\/span>\n    <span>Updated April 4, 2026<\/span>\n  <\/div>\n  <div class=\"kh-reviewed-body\">\n    <p><strong>How we reviewed this article:<\/strong><\/p>\n    <p>Kolana Health follows strict sourcing guidelines and relies on peer-reviewed studies, government agencies (CDC, NIH, HRSA, FDA), and established medical associations (DHHS, IDSA, IAS-USA). All content is reviewed by a licensed clinician before publication and updated when evidence changes. Learn more in our <a href=\"https:\/\/kolanahealth.com\/editorial-policy\/\" target=\"_blank\" rel=\"noopener\">editorial policy<\/a>.<\/p>\n    <span class=\"kh-ep-link\"><a href=\"https:\/\/kolanahealth.com\/editorial-policy\/\" target=\"_blank\" rel=\"noopener\">Read our editorial policy &rarr;<\/a><\/span>\n  <\/div>\n<\/div>\n\n\n<!-- REFERENCES -->\n<div class=\"kh-refs\">\n  <h2>Sources &amp; References<\/h2>\n  <ol>\n    <li>CDC &mdash; HIV Basics: <a href=\"https:\/\/www.cdc.gov\/hiv\/basics\/\" target=\"_blank\" rel=\"noopener noreferrer\">cdc.gov\/hiv\/basics<\/a><\/li>\n    <li>CDC &mdash; U=U: <a href=\"https:\/\/www.cdc.gov\/hiv\/risk\/estimates\/index.html\" target=\"_blank\" rel=\"noopener noreferrer\">cdc.gov<\/a><\/li>\n    <li>NIH DHHS &mdash; Guidelines for ART in Adults and Adolescents: <a href=\"https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-arv\" target=\"_blank\" rel=\"noopener noreferrer\">clinicalinfo.hiv.gov<\/a><\/li>\n    <li>PARTNER Study &mdash; Rodger AJ et al. (2019). <em>JAMA<\/em>: <a href=\"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2739993\" target=\"_blank\" rel=\"noopener noreferrer\">jamanetwork.com<\/a><\/li>\n    <li>HPTN 052 &mdash; Cohen MS et al. (2016). <em>NEJM<\/em>: <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1600693\" target=\"_blank\" rel=\"noopener noreferrer\">nejm.org<\/a><\/li>\n    <li>Ryan White HIV\/AIDS Program: <a href=\"https:\/\/ryanwhite.hrsa.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">ryanwhite.hrsa.gov<\/a><\/li>\n    <li>HRSA &mdash; Find HIV Care: <a href=\"https:\/\/findhivcare.hrsa.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">findhivcare.hrsa.gov<\/a><\/li>\n    <li>NASTAD &mdash; ADAP Watch: <a href=\"https:\/\/www.nastad.org\/adap-watch\" target=\"_blank\" rel=\"noopener noreferrer\">nastad.org\/adap-watch<\/a><\/li>\n    <li>Gilead Advancing Access: <a href=\"https:\/\/www.gileadadvancingaccess.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">gileadadvancingaccess.com<\/a><\/li>\n    <li>Gilead Price Info &mdash; Biktarvy WAC 2026: <a href=\"https:\/\/www.gileadpriceinfo.com\/biktarvy\" target=\"_blank\" rel=\"noopener noreferrer\">gileadpriceinfo.com<\/a><\/li>\n    <li>CDC &mdash; PrEP: <a href=\"https:\/\/www.cdc.gov\/hiv\/risk\/prep\/\" target=\"_blank\" rel=\"noopener noreferrer\">cdc.gov\/hiv\/risk\/prep<\/a><\/li>\n    <li>FDA &mdash; Biktarvy Prescribing Information (2025): <a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/210251s023lbl.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">accessdata.fda.gov<\/a><\/li>\n  <\/ol>\n<\/div>\n\n<\/div><!-- \/.kh -->\n","protected":false},"excerpt":{"rendered":"<p>Medically reviewed by Dr. Neha Mishra, MD &mdash; Written by Ray Ashton &mdash; Updated April 4, 2026 Editorial disclosure: Kolana [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-20","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.kalonahealth.com\/wp-json\/wp\/v2\/pages\/20","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kalonahealth.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.kalonahealth.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.kalonahealth.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kalonahealth.com\/wp-json\/wp\/v2\/comments?post=20"}],"version-history":[{"count":1,"href":"https:\/\/www.kalonahealth.com\/wp-json\/wp\/v2\/pages\/20\/revisions"}],"predecessor-version":[{"id":21,"href":"https:\/\/www.kalonahealth.com\/wp-json\/wp\/v2\/pages\/20\/revisions\/21"}],"wp:attachment":[{"href":"https:\/\/www.kalonahealth.com\/wp-json\/wp\/v2\/media?parent=20"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}